Intellectual Property

  • Over 25 years of intellectual policy experience specializing in patent practice and policy.
  •  Co-author of the US Patent and Trademark Office's Utility and Written Description Guidelines.
  • US representative to the OECD for establishment of gene patenting licensing best practice guidelines.
  • Member of  PTO/JPO/EPO trilateral study on biopharmaceutical patent examination standards.
  • Former USPTO Biopharmaceutical patent practice specialist.
  • Former Director, Division of Policy, National Institutes of Health, Office of Technology Transfer.

Biotechnology

  • Ph.D. in Molecular Genetics.
  • Industry neuropharmacology experience.
  • Fungal genetics.
  • Oncogene Research (c-fms, trk, c-myc, N-myc).
  • Embryonic Stem cell research.
  • Homologous recombination studies.
  • Transgenic animals.
  • Developmental biology.

    Blastocyst injection of modified embryonic stem cells.

    Blastocyst injection of modified embryonic stem cells.

Federal Rulemaking

  • Authored Federal Rules packages for Department of Commerce and Department of Health and Human Services.
  • Responded to public comments during rule making process.
  • Crafted federal practice guidance documents.

Administrative Procedure Act